Brief: FDA Issues Clearance For Rewalk 7 Exoskeleton
13/03/2025 14:57
March 13 (Reuters) - Lifeward Ltd 2RW.MU: FDA ISSUES CLEARANCE FOR REWALK 7 EXOSKELETON LIFEWARD LTD - TO BEGIN SALES OF REWALK 7 IN U.S. Source text: ID:nGNXbdrmSP Further company coverage: 2RW.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lifeward
See all newsBrief: Lifeward Announces Collaboration With Shirley Ryan Abilitylab To Expand Access For The Rewalk Personal Exoskeleton
Brief: Lifeward To Acquire Powered Upper Body Exoskeleton With Ai Capabilities
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM